Clinical Trial Update: Reduced Intensity Conditioning for MDS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced intensity conditioning for myelodysplastic syndrome; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Snippet

Sponsor: Ruijin Hospital | Conditions: MDS | Phase 2 | Status: NOT_YET_RECRUITING